A previous history of alveolar osteitis predisposed the patient to painful post-operative complications following molar or premolar tooth extraction. Topical metronidazole gel was ineffective in ...
Metronidazole (Metrogyl Gel) is an antibacterial agent, prescribed for trichomoniasis, amebiasis and other bacterial infections. It fights against bacteria in the body. The information provided on ...
Topical- As 0.75% preparation: Apply twice daily. Skin diseases also known as dermatologic disorders are many in number and so are their causes. The common skin diseases or skin disorders are usually ...
HAWTHORNE, N.Y., July 18, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its ...
Alembic Pharmaceuticals’ joint venture, Aleor Dermaceuticals, has received approval from the Food and Drug Administration for its generic Metrogel Gel (metronidazole gel, 1%). The topical gel is ...
A previous history of alveolar osteitis predisposed the patient to painful post-operative complications following molar or premolar tooth extraction. Topical metronidazole gel was ineffective in ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for ...
FORT WORTH, Texas, Jan. 12 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the availability of a new MetroGel(R) 1% Kit for the topical treatment of the inflammatory lesions of rosacea.
A Petaluma biotech company has received approval from the U.S. Food and Drug Administration for a new drug to treat rosacea, a common skin ailment. Dow Pharmaceutical Sciences developed the medicine ...
Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. Tolerability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results